CHILDREN'S COUGH & COLD RELIEF SYRUP Canada - English - Health Canada

children's cough & cold relief syrup

crls - pseudoephedrine hydrochloride; dextropropoxyphene hydrochloride - syrup - 15mg; 7.5mg - pseudoephedrine hydrochloride 15mg; dextropropoxyphene hydrochloride 7.5mg

Warfarin Teva 0.5mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 0.5mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 0.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extensiona and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 1 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 1 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 1 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 2 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 2 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 2.5 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 2.5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 10 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 10 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 10 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 7.5 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 7.5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 7.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 6 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 6 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 6 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 5 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 5 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 3 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

warfarin teva 3 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 3 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.